Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 117

    1.

    Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario.

    Choi YH, Cotterchio M, McKeown-Eyssen G, Neerav M, Bapat B, Boyd K, Gallinger S, McLaughlin J, Aronson M, Briollais L.

    Hered Cancer Clin Pract. 2009 Aug 23;7(1):14.

    PMID:
    19698169
    [PubMed]
    Free PMC Article
    2.

    Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.

    Kopciuk KA, Choi YH, Parkhomenko E, Parfrey P, McLaughlin J, Green J, Briollais L.

    Hered Cancer Clin Pract. 2009 Oct 28;7(1):16.

    PMID:
    19863818
    [PubMed]
    Free PMC Article
    3.

    Risk of pancreatic cancer in families with Lynch syndrome.

    Kastrinos F, Mukherjee B, Tayob N, Wang F, Sparr J, Raymond VM, Bandipalliam P, Stoffel EM, Gruber SB, Syngal S.

    JAMA. 2009 Oct 28;302(16):1790-5.

    PMID:
    19861671
    [PubMed - indexed for MEDLINE]
    4.

    Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

    Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB.

    Gastroenterology. 2009 Nov;137(5):1621-7. Epub 2009 Jul 18.

    PMID:
    19622357
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC).

    Geary J, Sasieni P, Houlston R, Izatt L, Eeles R, Payne SJ, Fisher S, Hodgson SV.

    Fam Cancer. 2008;7(2):163-72. Epub 2007 Oct 16.

    PMID:
    17939062
    [PubMed - indexed for MEDLINE]
    6.

    Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands.

    Capelle LG, Van Grieken NC, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, Vasen HF, Kuipers EJ.

    Gastroenterology. 2010 Feb;138(2):487-92. Epub 2009 Nov 10.

    PMID:
    19900449
    [PubMed - indexed for MEDLINE]
    7.

    Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors.

    Aaltonen L, Johns L, Järvinen H, Mecklin JP, Houlston R.

    Clin Cancer Res. 2007 Jan 1;13(1):356-61.

    PMID:
    17200375
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States.

    Kastrinos F, Stoffel EM, Balmaña J, Steyerberg EW, Mercado R, Syngal S.

    Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2044-51.

    PMID:
    18708397
    [PubMed - indexed for MEDLINE]
    Free Article
    9.

    Age-Dependent Cancer Risk Is Not Different in between MSH2 and MLH1 Mutation Carriers.

    Olschwang S, Yu K, Lasset C, Baert-Desurmont S, Buisine MP, Wang Q, Hutter P, Rouleau E, Caron O, Bourdon V, Thomas G.

    J Cancer Epidemiol. 2009;2009:791754. Epub 2009 Mar 8.

    PMID:
    20445804
    [PubMed]
    Free PMC Article
    10.

    Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study.

    Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ET, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FB, Leter EM, Gille JJ, Aalfs CM, Redeker EJ, Hes FJ, Tops CM, van Nesselrooij BP, van Gijn ME, Gómez García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, Oláh E, Chan TL, Leung SY, van Kessel AG, Kiemeney LA, Hoogerbrugge N, Ligtenberg MJ.

    Lancet Oncol. 2011 Jan;12(1):49-55. Epub 2010 Dec 8.

    PMID:
    21145788
    [PubMed - indexed for MEDLINE]
    11.

    Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.

    Boilesen AE, Bisgaard ML, Bernstein I.

    Acta Obstet Gynecol Scand. 2008;87(11):1129-35.

    PMID:
    18972272
    [PubMed - indexed for MEDLINE]
    12.

    Prediction of Lynch syndrome in consecutive patients with colorectal cancer.

    Green RC, Parfrey PS, Woods MO, Younghusband HB.

    J Natl Cancer Inst. 2009 Mar 4;101(5):331-40. Epub 2009 Feb 24.

    PMID:
    19244167
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Estimating cancer risk in HNPCC by the GRL method.

    Alarcon F, Lasset C, Carayol J, Bonadona V, Perdry H, Desseigne F, Wang Q, Bonaïti-Pellié C.

    Eur J Hum Genet. 2007 Aug;15(8):831-6. Epub 2007 May 2.

    PMID:
    17473834
    [PubMed - indexed for MEDLINE]
    Free Article
    14.

    A prospective, multicenter, population-based study of BRAF mutational analysis for Lynch syndrome screening.

    Bessa X, Ballesté B, Andreu M, Castells A, Bellosillo B, Balaguer F, Castellví-Bel S, Paya A, Jover R, Alenda C, Titó L, Martinez-Villacampa M, Vilella A, Xicola RM, Pons E, Llor X; Gastrointestinal Oncology Group of Spanish Gastroenterological Association.

    Clin Gastroenterol Hepatol. 2008 Feb;6(2):206-14. Epub 2007 Dec 21.

    PMID:
    18096441
    [PubMed - indexed for MEDLINE]
    15.

    The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations.

    Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A.

    Gastroenterology. 2008 Aug;135(2):419-28. Epub 2008 May 2.

    PMID:
    18602922
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers.

    Houlle S, Charbonnier F, Houivet E, Tinat J, Buisine MP, Caron O, Benichou J, Baert-Desurmont S, Frebourg T.

    Eur J Hum Genet. 2011 Aug;19(8):887-92. doi: 10.1038/ejhg.2011.44. Epub 2011 Mar 16.

    PMID:
    21407259
    [PubMed - indexed for MEDLINE]
    17.

    Cancer Risks for the Relatives of Colorectal Cancer Cases with a Methylated MLH1 Promoter Region: Data from the Colorectal Cancer Family Registry.

    Levine AJ, Win AK, Buchanan DD, Jenkins MA, Baron JA, Young JP, Long TI, Weisenberger DJ, Laird PW, McCall RL, Duggan DJ, Haile RW.

    Cancer Prev Res (Phila). 2012 Jan 17. [Epub ahead of print]

    PMID:
    22144422
    [PubMed - as supplied by publisher]
    18.

    Germ-line mutations in mismatch repair genes associated with prostate cancer.

    Grindedal EM, Møller P, Eeles R, Stormorken AT, Bowitz-Lothe IM, Landrø SM, Clark N, Kvåle R, Shanley S, Maehle L.

    Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2460-7. Epub 2009 Sep 1.

    PMID:
    19723918
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.

    Talseth-Palmer BA, McPhillips M, Groombridge C, Spigelman A, Scott RJ.

    Hered Cancer Clin Pract. 2010 May 21;8(1):5.

    PMID:
    20487569
    [PubMed]
    Free PMC Article
    20.

    Thyroid cancer in a patient with a germline MSH2 mutation. Case report and review of the Lynch syndrome expanding tumour spectrum.

    Stulp RP, Herkert JC, Karrenbeld A, Mol B, Vos YJ, Sijmons RH.

    Hered Cancer Clin Pract. 2008 Feb 15;6(1):15-21.

    PMID:
    19706203
    [PubMed]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk